Fig. 2From: Initiation of Somatostatin analogues for neuroendocrine tumor patients: a cost-effectiveness analysisTornado Diagram – Incremental Cost-Effectiveness Ratio (ICER). The bars indicate the ICERs that result from the range of parameter inputs. NET = Neuroendocrine Tumor; SSA = somatostatin analogues; PRRT = Peptide Receptor Radionuclide Therapy; EV = expected value in base caseBack to article page